Does your memory cause you daily problems? Interested in improving your metabolic health? If you are 65 or older and overweight, you may qualify for a research study examining whether changing the timing of your eating habits can improve your metabolic and brain health.

Are you between 18 and 45 years of age and diagnosed with multiple sclerosis, without MS relapses within the past year? Are you currently prescribed with MS medication? If so, you may be able to participate in a research study examining whether a switch to a high-efficacy medication- Ofatumumab, would work better for you than your current treatment.

Do you have a diagnosis of Schizophrenia? Are you interested in improving your cognitive functioning? If so, you may be eligible to participate in a research study to find out if a new medication "RL-007" improves mental functioning.

People with Parkinson disease often develop difficulty walking. Metronomes are thought to help improve walking. We believe that setting metronomes slower while walking on a treadmill and faster when walking over the ground may target certain portions of gait. Our goal is to create beneficial changes in the way that people walk that persist and can be seen in the long-term.

We are doing a research study of people who both smoke and vape. The purpose of this study is to learn more about your opinions on health messages.

Interested in a PrEP study? This is a study exploring a new, investigational HIV PrEP medication, Lenacapavir. This medication is given as an injection just under the skin, every 6 months or twice a year. We would like to find out how effective this new, investigational medication is in preventing HIV, in the hopes of expanding access and options for HIV PrEP.

If you have been diagnosed with knee osteoarthritis and have daily knee pain, you may qualify to participate in our study.

This is a research study to investigate how collecting information about treatment-related side effects directly from patients can help manage the side effects associated with certain oral chemotherapies in patients with metastatic renal cell carcinoma.

This research study is studying proteins in the blood of patients with early-stage breast cancer. We want to see if these proteins can predict the occurrence of damage to the ends of nerves in hands and feet, which is a side-effect called chemotherapy induced peripheral neuropathy (CIPN). There is currently no test to check risk of CIPN. Researchers hope to use the results of this study to create a new test that would identify patients at increased risk of CIPN and help doctors select the best treatment and post-treatment care for their patients and improve patient recovery after chemotherapy.

Have you been diagnosed with Leukemia and looking for another treatment option? Do you have Myelofibrosis (MF), myelodysplastic syndrome (MDS) and /or myelodysplastic/myeloproliferative overlap syndrome (MDS/MPN)? You may be able to take part in this study to find out the safety and effectiveness of a study drug.